⌘K

Login Start Free

Home/Filings/4/0001946439-25-000010

4//SEC Filing

Davis Krista 4

Accession 0001946439-25-000010

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 4:14 PM ET

Size

5.0 KB

Accession

0001946439-25-000010

Insider Transaction Report

Form 4

Period: 2025-03-19

ANI PHARMACEUTICALS INCANIP

SVP, CHIEF HR OFFICER

Transactions

Sale
Common Stock
2025-03-19$65.00/sh−1,866$121,290→ 64,659 total

Footnotes (1)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.

Documents

1 file

4
wk-form4_1742501635.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001946439

Filing Metadata

Form type: 4
Filed: Mar 19, 8:00 PM ET
Accepted: Mar 20, 4:14 PM ET
Size: 5.0 KB

View on SEC.gov